Trial intelligence / Profile preview

[14C] Oxaliplatin Microdosing in Advanced Colorectal Cancer

NCT02569723Completed

Start
Oct 2015
Primary completion
Apr 2018
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Open-label trial of oxaliplatin in colorectal adenocarcinoma. Started Oct 2015; status: completed.

02

Drugs

oxaliplatin
03

Conditions

colorectal adenocarcinoma

Beyond the preview

Go deeper on NCT02569723.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02569723.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call